-
Bikaji Foods
721.20 520.00(%) -
Transrail Light
800.00 807.00(%) -
Godfrey Phillips
10,810.55 9,891.25(%) -
Newgen Software
977.35 1,795.50(%) -
Waaree Energies
3,223.90 3,740.75(%) -
Jayaswal Neco
52.82 26.06(%) -
Reliance Power
43.06 29.21(%) -
Aditya Infotech
1,025.20 1,014.65(%) -
Le Travenues
226.80 118.65(%) -
Bharti Airtel
1,965.00 2,045.50(%) -
Tata Motors
650.45 542.55(%) -
NCC
220.80 334.15(%) -
Mazagon Dock
2,761.00 1,917.95(%) -
Swiggy
398.70 617.00(%) -
Zinka Logistics
569.90 548.00(%) -
Kirloskar Oil
945.00 1,404.95(%) -
Larsen & Toubro
3,628.85 2,967.65(%) -
HDFC Bank
1,983.15 2,036.30(%) -
One 97
1,070.60 1,128.00(%) -
Bharat Electron
393.45 435.95(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Unichem Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 577.0
- ISIN : INE351A01035
-
Today’s Low
534.00 -
Today’s High
569.60

-
Open
559.00 -
Perv Close
562.15 -
52W Low
533.30 -
52W High
937.95
Key Indicators
-
P/E(TTM)
27.91
-
Mar.Cap (₹Cr.)
3,798.74
-
Div & Yield %
0.00
-
Book Value(₹)
349.37
-
Debt-Equity Ratio
-4.02
-
AGM Date
05-Aug-2025
-
EPS
19.31
-
P/E Ratio
27.91
Financials Ratios
-
Debt-Equity Ratio
0.12
-
Mar.Cap (₹Cr.)
3,798.74
-
RONW (%)
-1.79
-
ROCE (%)
-0.23
Score Board
-
Equity (₹ in Cr.)
14.08
-
BV (₹)
349.40
-
Sales( ₹ in Cr.)
1,735.70
-
NP (in Cr.)
158.54
-
NP Var(%)
537.0
-
Div%
0.0
-
CPS (₹)
37.90
-
EPS (₹)
22.50
-
Traded Value (₹ in Lakhs)
3,794.52
-
52 Week High
937.95
-
52 Week Low
533.30
-
Price BSE
539.0
-
Price NSE
540.00
-
Market Capital( in Cr.)
3,794.52
-
P/C Ratio
14.20
-
P/E Ratio
23.90
-
Price Vs.BV
22.50
-
04-Aug-2025( 03:32)
Results - Announcements - Unich... - Net loss of Unichem Laboratori...
-
16-Jul-2025( 10:10)
Corporate News - Unich... - Unichem Laboratories will hold...
-
23-Jun-2025( 09:53)
Hot Pursuit - Unich... - In a regulatory filing, the co...
-
21-Jun-2025( 03:21)
Corporate News - Unich... - Unichem Laboratories announced...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 1,735.70 | 1,442.16 | 1,072.43 | 942.93 | 1,123.97 | 904.44 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 1,735.70 | 1,442.16 | 1,072.43 | 942.93 | 1,123.97 | 904.44 |
Other Income | 44.83 | 98.40 | 41.85 | 42.07 | 47.37 | 99.17 |
Stock Adjustments | 33.33 | 26.35 | -22.01 | 52.79 | 16.73 | 18.50 |
Total Income | 1,813.86 | 1,566.91 | 1,092.27 | 1,037.79 | 1,188.07 | 1,022.11 |
EXPENDITURE : | ||||||
Raw Materials | 830.62 | 717.82 | 501.86 | 436.27 | 449.67 | 401.25 |
Power and Fuel Cost | 106.63 | 105.64 | 101.41 | 77.12 | 67.95 | 72.14 |
Employee Cost | 287.51 | 283.15 | 270.86 | 250.79 | 234.04 | 205.16 |
Other Manufacturing Expenses | 78.10 | 74.62 | 70.61 | 73.49 | 64.48 | 68.09 |
Selling and Administration Expenses | 190.81 | 213.59 | 194.89 | 192.65 | 225.80 | 263.43 |
Miscellaneous Expenses | 21.48 | 148.40 | 116.36 | 8.95 | 3.28 | 3.48 |
Employee Benefit Expenses | 287.51 | 283.15 | 270.86 | 250.79 | 234.04 | 205.16 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 1,515.15 | 1,543.22 | 1,256.00 | 1,039.27 | 1,045.23 | 1,013.55 |
Operating Profit | 298.71 | 23.69 | -163.73 | -1.49 | 142.84 | 8.56 |
Interest | 7.62 | 10.42 | 9.38 | 2.07 | 1.30 | 1.28 |
Gross Profit | 291.09 | 13.27 | -173.11 | -3.56 | 141.54 | 7.28 |
Depreciation | 108.41 | 105.45 | 105.98 | 83.19 | 75.89 | 71.09 |
Profit Before Tax | 182.68 | -92.18 | -279.09 | -86.75 | 65.65 | -63.81 |
Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 19.72 | 0.00 | 20.61 | -31.32 | 11.56 | -7.50 |
Reported Net Profit | 162.96 | -92.18 | -299.70 | -55.43 | 54.08 | -56.32 |
Extraordinary Items | 4.42 | -55.94 | -103.16 | -0.25 | 0.02 | -1.45 |
Adjusted Net Profit | 158.54 | -36.24 | -196.54 | -55.18 | 54.06 | -54.87 |
Adjustment below Net Profit | 0.00 | 0.00 | 121.81 | 0.00 | 0.00 | 0.00 |
P & L Balance brought forward | 2,279.18 | 2,359.31 | 2,565.36 | 2,648.96 | 2,623.04 | 2,712.21 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | -2.89 | -12.05 | 28.16 | 28.16 | 28.16 | 32.85 |
P & L Balance carried down | 2,445.03 | 2,279.18 | 2,359.31 | 2,565.36 | 2,648.96 | 2,623.04 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 0.00 | 0.00 | 200.00 | 200.00 | 200.00 | 200.00 |
Dividend Per Share(Rs) | 0.00 | 0.00 | 4.00 | 4.00 | 4.00 | 4.00 |
Earnings Per Share-Unit Curr | 23.15 | -13.09 | -42.57 | -7.87 | 7.68 | -8.00 |
Earnings Per Share(Adj)-Unit Curr | 23.15 | -13.09 | -42.57 | -7.87 | 7.68 | -8.00 |
Book Value | 349.40 | 325.94 | 338.65 | 379.52 | 383.11 | 375.99 |
Book Value(Adj)-Unit Curr | 349.40 | 325.94 | 338.65 | 379.52 | 383.11 | 375.99 |